Patents for C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732) |
---|
06/28/2006 | CN1795190A Compounds and methods for the treatment or prevention of flavivirus infections |
06/28/2006 | CN1795172A Continuous process for preparing caprolactam |
06/28/2006 | CN1795171A Continuous process for preparing caprolactam |
06/28/2006 | CN1261434C Method for separating high-purity galanthamine from short-tube lycoris crude extract |
06/28/2006 | CN1261430C Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists |
06/27/2006 | US7067510 5-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-5,11-dihydro-6-oxa-12-thia-dibenzo[a,f]azulen-2-ol; 13-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-7,13-dihydro-12-oxa-benzo[4,5]cyclohepta[1,2-a]naphthalen-3-ol or derivatives or salts; for alleviating symptoms of estrogen deprivation, including bone loss |
06/22/2006 | WO2006064757A1 Aminocarboxylic acid derivative and medicinal use thereof |
06/22/2006 | US20060135762 Preventing the deposits of amyloid protein, treating neurodegenerative disease, Alzheimer's disease and Down's Syndrome; {[carbamoyl]cycloalkyl}-N-(2-oxo-5-phenyl((S)-3H-benzo[f]1,4-diazepin-3-yl))- or (2-oxo-5-phenyl((S)-3H-benzo[f]1,4-diazepin-3-yl))-carboxamide |
06/22/2006 | CA2591399A1 Aminocarboxylic acid derivative and medicinal use thereof |
06/21/2006 | EP1670768A1 Compounds and methods for treating dyslipidemia |
06/21/2006 | EP1670456A2 Compounds, compositions and methods |
06/21/2006 | EP1501516B1 A process for the preparation of benazepril hydrochloride |
06/21/2006 | CN1260229C Method for separating lycoramine from plant extract |
06/21/2006 | CN1260228C Method for separating galanthamine from plant extract |
06/20/2006 | US7064211 Hemiasterlin derivatives and uses thereof |
06/20/2006 | US7064200 Process for the synthesis of 1,3,4,5-tetrahydro-2H-3-benzazepin-2-one compounds, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid |
06/20/2006 | US7064123 substituted acetamides; uses for treating diseases including arthritis, muscular dystrophy, inflammation, tumor invasion, glomerulonephritis, malaria, periodontal disease, and metachromatic leukodystrophy |
06/20/2006 | US7064121 benzodiazepine derivatives that may be fused to a pyrroline or piperidine ring; e.g., N-[1 (R)-(3-Aminopropylcarbamoyl)-2-(naphthalen-2-yl)ethyl]-3-(5,11-dioxo-2,3-dihydro-1H-(11aS)-pyrrolo[2,1-c][1,4]benzodiazepin-10-yl)propionamide; increasing levels of endogenous growth hormones in humans and animals |
06/15/2006 | WO2006039383A3 Synthesis by chiral diamine-mediated asymmetric alkylation |
06/15/2006 | US20060128752 Chemical compounds |
06/14/2006 | CN1259310C Process for extracting and separating caprolactam from amide oil |
06/13/2006 | US7060819 Hydrogenation using hydrogenation catalyst; distillation |
06/08/2006 | WO2006060225A2 Process for asymmetric synthesis of hexahydropyrimido[1,2-a] azepine-2-carboxamides and related compounds |
06/08/2006 | US20060122170 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzazepine derivative or salt thereof |
06/08/2006 | US20060122169 Succinoylamino benzodiazepines as inhibitors of Abeta protein production |
06/08/2006 | US20060121090 Ocular compositions that increases the activity of gelatinase a in ocular cells |
06/07/2006 | EP1664088A2 Hemiasterlin derivatives and uses thereof |
06/07/2006 | EP1663996A1 (thio)carbamoyl-cyclohexane derivatives as d3/d2 receptor antagonists |
06/07/2006 | EP1663984A2 Process for preparation of benazepril |
06/07/2006 | EP1663201A1 A use of novel 2-oxo-heterocyclic compounds and the pharmaceutical compositions comprising the same |
06/07/2006 | CN1781908A Process for preparing epsilon-hexanolactam by catalyzing cyclohexanone-oxime rearranging |
06/01/2006 | WO2006057460A1 Nitrogen-containing fused ring compound and use thereof |
06/01/2006 | WO2006056696A2 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof |
06/01/2006 | WO2006056695A1 Bengamides with a substituted caprolactame cycle, method for the preparation thereof, compositions containing them and use thereof |
06/01/2006 | WO2006056339A1 A process for the preparation of (s)-(+)-10,11-dihydro-10-hydroxy-5h-dibenz (b,f) azepine-5-carboxyamide |
06/01/2006 | CA2595305A1 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof |
06/01/2006 | CA2589147A1 A process for the preparation of (s)-(+)-10,11-dihydro-10-hydroxy-5h-dibenz (b,f) azepine-5-carboxyamide |
06/01/2006 | CA2585990A1 Bengamides with a substituted caprolactame cycle, method for the preparation thereof, compositions containing them and use thereof |
05/31/2006 | EP1660454A1 Azacyclic compounds as inhibitors of sensory neurone specific channels |
05/31/2006 | EP1660436A1 Cathepsin inhibitors |
05/31/2006 | EP1210332B1 Bleach boosting components, compositions and laundry methods |
05/31/2006 | CN1780819A 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzoazepine derivative or salt of the same |
05/31/2006 | CN1778796A Production of hexyl lactam in ion liquid |
05/31/2006 | CN1778795A Production of hexyl lactam |
05/30/2006 | US7053211 Process for the preparation of α-aminosubstituted carboxylic acid amides |
05/30/2006 | US7053084 Antagonist for preventing the deposits of amyloid protein, for treating neurodegenerative disease, Alzheimer's disease and Down's Syndrome; (2R,3S) N1-[1,3-dihydro-1-methyl-2-oxo-5-phenyl-2H-1,4-benzodiazepin-3-yl]-2-(2-methylpropyl)-3-allyl-butanediamide |
05/30/2006 | US7053081 Cyclic malonamides as inhibitors of A-β protein production |
05/30/2006 | CA2157668C Tricyclic 2,3,4,5-tetrahydro-1h-3-benzazepines, their use and preparation |
05/26/2006 | WO2006053683A2 Gene silencing using sense dna and antisense rna hybrid constructs coupled to peptides facilitating the uptake into cells |
05/26/2006 | WO2006053674A2 A process for the preparation of 10,11-dihydro-10-hydroxy-5h-dibenz[b,f]azepine-5-carboxyamide |
05/26/2006 | CA2587486A1 A process for the preparation of 10,11-dihydro-10-hydroxy-5h-dibenz[b,f]azepine-5-carboxyamide |
05/25/2006 | US20060111567 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |
05/25/2006 | US20060111339 Novel oral general anesthetics and metabolitically resistant anticonvulsants |
05/24/2006 | CN1777423A Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
05/24/2006 | CN1775752A Optical pure diamide compound and its use |
05/24/2006 | CN1257161C Meptazinol prodrug and its salts and its production method |
05/23/2006 | US7049326 Altering a drug's distribution, metabolism and elimination properties, especially by modifying with aralkyl ester moieties to increase rate of metabolism to inactive and nontoxic metabolites when exposure is halted; surgery, riots |
05/23/2006 | US7049311 Pyrrolbenzodiazepines |
05/18/2006 | US20060106009 Use of caboxamides for the treatment of tinnitus |
05/18/2006 | CA2586370A1 Constrained compounds as cgrp-receptor antagonists |
05/17/2006 | EP1656352A1 6-(2,2,2-TRIFLUOROETHYLAMINO)-7-CHLORO-2,3,4,5-TETRAHYDRO-1H-BENZO d AZEPINE AS A 5-HT sb 2c /sb RECEPTOR AGONIST |
05/16/2006 | US7045622 Process for producing lactam |
05/16/2006 | CA2204261C Improved method for preparing opipramol |
05/11/2006 | US20060096869 Apparatus and process for the synthesis of hydrogen peroxide directly from hydrogen and oxygen |
05/10/2006 | EP1656002A2 Organic light emitting device |
05/09/2006 | US7041662 Substituted benzo [b] azepin-2-one compounds |
05/08/2006 | CA2497031A1 Farnesyl dibenzodiazepinones, processes for their production and their use as pharmaceuticals |
05/04/2006 | WO2006047503A2 Inhibitors of c-fms kinase |
05/04/2006 | WO2006047479A2 C-fms kinase inhibitors |
05/04/2006 | WO2006046039A2 Tetracyclic indole derivatives as antiviral agents |
05/04/2006 | WO2006032994A3 Muscarinic receptor antagonists |
05/04/2006 | CA2585113A1 Tetracyclic indole derivatives as antiviral agents |
05/03/2006 | EP1651633A1 Substituted lactams and their use as anti-cancer agents |
05/03/2006 | CN1254474C Tetrahydroazepine derivatives useful as dopamine d3 receptor modulators (antipsychotic agents) |
04/27/2006 | WO2005096709A3 A process for the preparation of 10,11-dihydro-10-oxo-5h-dibenz[b,f]azepine-5-carboxamide |
04/27/2006 | US20060089357 Novel compounds and compositions as cathepsin inhibitors |
04/27/2006 | US20060089347 Substituted azepines as histamine h3 receptor antagonists, preparation and therapeutic uses |
04/27/2006 | US20060089346 Optionally fused aryl-substituted azepanones, oxazepanone or thiazepanones substituted with a dipeptide group, e.g., N2-[(3,5-difluorophenyl)acetyl]-N1-[(2R,3R)-2-(2,5-difluorophenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl]-L-alaninamide; secretase inhibitors for treating Alzheimer's disease |
04/26/2006 | EP1648872A2 Aryl fused azapolycyclic compounds |
04/26/2006 | CN1253554C acidophilic bacteria strain with nitrile hydrolase activity |
04/26/2006 | CN1253441C Protease inhibitors |
04/25/2006 | US7034110 Method of identifying chemical compounds having selected properties for a particular application |
04/19/2006 | EP1646623A2 5-h-benzo[d]naphth[2,1-b]azepine derivative as selective d1/d5 receptor antagonists for the treatment of obesity and cns disorders |
04/19/2006 | EP1487801B1 7-arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo¬d|azepine derivatives with 5-ht6 receptor affinity for the treatment of cns disorders |
04/19/2006 | CN1252050C Process for recovering caprolactam from aqueous caprolactam product using in situ prepared alkali amino caproate |
04/18/2006 | US7030138 Benzamidine derivatives |
04/18/2006 | US7030116 Compounds and compositions as cathepsin inhibitors |
04/13/2006 | WO2005118549A3 Compounds having affinity for dopamine d3 receptor and uses thereof |
04/13/2006 | US20060079505 Modulators of muscarinic receptors |
04/13/2006 | US20060079499 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
04/13/2006 | DE19637425B4 Neue N-Vinyllactam-Derivate und deren Polymere New N-vinyl lactam derivatives and their polymers |
04/12/2006 | EP1644321A2 New benzamides as ppaty modulators |
04/12/2006 | EP0903337B1 Process for the preparation of 1-alkoxycarbonyl-3-phenylpropyl derivatives |
04/12/2006 | CN1759101A Quinolinone / benzoxazinone derivatives and uses thereof |
04/12/2006 | CN1758942A Distillative method for separating hexamethylenediamine from a mixture comprising hexamethylenediamine, -aminocapronitrile and tetrahydroazepine |
04/12/2006 | CN1250528C Cyclic nitrones and pharmaceutical compositions containing them |
04/11/2006 | US7026474 Method for producing ε-caprolactam and method for reactivating catalyst for production of ε-caprolactam |
04/11/2006 | US7026473 Process for the carbonylation of pentenenitrile |
04/11/2006 | US7026358 Oral general anesthetics and metabolitically resistant anticonvulsants |
04/11/2006 | CA2322558C Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel |